Articles tagged with Medicinal Chemistry
Researchers developed mucoadhesive films combining xyloglucan and green tea extract to treat oral mucositis, a painful inflammation caused by cancer treatment. The films demonstrated high strength and adhesion forces comparable to commercial products, showing promise as a novel treatment for oral mucositis.
Researchers used drum mills to manufacture kilograms of ibuprofen-nicotinamide, a formulation that improves therapeutic efficacy and stability. The study demonstrates the possibilities of drum mills for large-scale synthesis of pharmaceutical co-crystals.
Researchers created new proteins using AI that bind to and neutralize deadly snake toxins, providing a safer alternative to traditional antivenoms. The study's results show an 80-100% survival rate in mice, offering potential benefits for people in developing countries.
Researchers have discovered a new target for antibiotics, the methylerythritol phosphate pathway, which is essential for bacteria's energy metabolism. By blocking this pathway, bacteria can be killed without affecting human cells.
A new position paper from the International Osteoporosis Foundation and International Federation of Clinical Chemistry proposes a unified nomenclature for bone status indices to enhance diagnostic consistency and clarity. The guidelines offer a comprehensive framework to unify terminology and improve comparability across studies.
The Institute of Physical Chemistry of the Polish Academy of Sciences has developed a novel system for determining potassium levels in liquid food samples using fast and non-destructive techniques. The low-cost, ion-selective syringe electrodes offer excellent selectivity and linear range, making them suitable for point-of-care devices.
Researchers found that carrots can enhance the body's ability to regulate blood sugar and positively influence the composition of gut bacteria. The study used mice with type 2 diabetes and found improved glucose tolerance after consuming carrot powder.
ISM1745, a potentially best-in-class small molecule inhibitor, has been nominated as a preclinical candidate for the treatment of MTAP-deleted cancers. It targets Protein arginine methyltransferase 5 (PRMT5), which is elevated in various cancers and correlates with poor prognostic outcomes.
Researchers at Vanderbilt University have successfully completed a phase I clinical trial of VU319, a drug that increases the efficacy of acetylcholine at the M1 receptor, showing promise as an Alzheimer's treatment. The trial demonstrated no side effects and target engagement at the highest dose tested.
A new two-step approach to functionalize complex molecules simplifies the synthesis of piperidines, a key component in many pharmaceuticals. This innovation reduces multistep processes from 7-17 steps to just 2-5, improving efficiency and cost.
Researchers have developed a molecule called azo-menthol that precisely controls TRPM8 channels using light, enabling spatiotemporally precise and reversible activation and deactivation. This breakthrough has great therapeutic potential for diseases such as cancer, metabolic disorders, and inflammations.
The study uses generative AI to identify and optimize potent and selective HPK1 inhibitors for immunotherapy. The results show a relatively balanced candidate compound with adequate in vitro ADME, in vivo PK properties, good oral bioavailability, and robust in vivo efficacy in various cancer models.
Scientists at Insilico Medicine developed a novel gut-restricted PHD inhibitor using generative chemistry engine Chemistry42, promising to repair intestinal mucosal barriers and regulate immune responses in IBD. The compound, ISM5411, demonstrated significant anti-colitis activity without systemic side effects.
Researchers achieved control over competing reaction outcomes by selectively manipulating charge states and specific resonances through targeted energy injection. This breakthrough has profound implications for pharmaceutical research, potentially improving efficiency and sustainability.
Bentham Science journals Central Nervous System Agents in Medicinal Chemistry and CNS & Neurological Disorders – Drug Targets accepted for PsycInfo database indexing, enhancing global visibility of research. PsycInfo provides extensive coverage of behavioral and social sciences, making this move a significant step forward.
Professor Lutz Nuhn aims to create lipid-free capsules for RNA vaccines that don't require cooling and can initiate precise immune responses. He plans to equip the capsules with messenger substances to target cancer as well.
Insilico Medicine has developed an innovative platform using generative AI to discover novel molecules. The company has nominated over 20 preclinical candidates and received IND clearance for 10 molecules.
Julian West, assistant professor of chemistry at Rice, recognized for harnessing free radical intermediates through inner sphere photocatalysis. His work holds significant implications for organic synthesis and developing next-generation therapeutics and materials.
A new research grant aims to develop kinase inhibitors for treating type 1 diabetes, with a focus on preventing and reversing the condition. The grant is made through C-Path's TRxA program in partnership with The Leona M. and Harry B. Helmsley Charitable Trust.
Researchers at Maynooth University are leading a two-year study to develop non-abrasive bandages that can be sprayed onto the skin and melted away painlessly. The goal is to reduce the agony experienced by those living with Epidermolysis Bullosa, a genetic skin condition affecting over 500,000 children and adults worldwide.
Researchers at New York University developed a mathematical approach, Crystal Math, to predict molecular crystal structures in hours, bypassing weeks or months of supercomputer processing. This breakthrough could speed up R&D for drugs and electronic devices.
Anthocyanins, widely studied for antioxidant and anticancer properties, break down easily due to environmental conditions. Researchers developed pectin-coated nanoparticles to improve bioavailability, absorption efficiency, and targeted delivery.
Pharma.AI Week will showcase the latest advancements in Insilico's generative AI platform, including PandaOmics and Science42, with expert speakers and hands-on demos. The event aims to empower researchers and scientists with tools for faster and more accurate discoveries.
Researchers have made significant strides toward creating inhalable mRNA medicines using a novel lipid-polymer nanoparticle. The nanoparticles successfully deliver aerosols to mice's lungs and demonstrate uniform protein expression in tissues.
A recent Stanford University study has identified 33 current faculty members from Binghamton University as among the top 2% of all researchers worldwide in their fields. The researchers were ranked based on their career-long or single-year output and citation metrics, indicating their significant impact on their respective fields.
Chemists at Emory University and Caltech have developed a revolutionary strategy for functionalizing carbon-hydrogen bonds, transforming low-cost materials into complex building blocks of organic chemistry. The breakthrough enables the synthesis of complex natural molecules with antimicrobial properties.
A study of human skeletal remains from the Tudor warship Mary Rose reveals that handedness may influence clavicle bone chemistry as people age. The analysis found increased mineral content and decreased protein content in right clavicles compared to left, suggesting repeated stress on the right side during activities like sailing.
Researchers have identified a unique multidomain enzyme capable of catalysing two separate reactions, cyclization and hydroxylation, on a single peptide substrate. This breakthrough discovery opens the possibility of developing innovative drug molecules with potential therapeutic applications for life-threatening infections and cancer.
A new study reveals widespread resistance of Pseudomonas aeruginosa to commonly used cleaning agents, including quaternary ammonium compounds. The researchers identify biocides that work well against the pathogen, highlighting the need for revised sanitation protocols in hospitals and homes.
UTEP researchers developed a portable device that can detect colorectal and prostate cancer quickly and accurately, reducing the need for costly instruments. The device is low-cost, sensitive, and analyzes samples in just an hour.
A team of researchers from the University of Bonn has trained a chemical language model to predict potential active ingredients with special properties. The AI was able to reproduce the chemical structures of compounds with known dual-target activity, which may be effective in treating various diseases.
The Max Planck Institute team has developed a strategy to extend mRNA lifespan by protecting it from degradation. This protects potentially health-promoting proteins, such as tumor suppressors and nuclear receptors, from premature breakdown.
Researchers at KAIST successfully developed single-atom editing technology that maximizes drug efficacy by converting oxygen atoms into nitrogen atoms in furan compounds. This breakthrough technology enables selective editing of complex natural products or pharmaceuticals, opening new doors for building libraries of drug candidates.
Researchers have developed a new chemical reaction to synthesize selectively left- or right-handed versions of mirror molecules, which differ in their biological effects. The new method enables the rapid and efficient production of pure enantiomers, paving the way for testing potential uses against various conditions.
Recent research highlights microwave-induced synthesis as a transformative potential in drug discovery and development. This efficient technique enables rapid preparation of diverse N-heterocycles, including biologically active molecules such as pyrimidines, thiazoles, and quinolines.
The University of Liverpool will lead a £60m national research hub to develop and manufacture new long-acting therapeutics, positioning the UK as a global leader in this field. The Hub for Advanced Long-acting Therapeutics (HALo) aims to create new proof-of-concept medicine candidates for diseases like high blood pressure and asthma.
Recent research highlights the multifaceted potential of chestnut tannin in various sectors, including its use as a replacement for antibiotics in animal feed and as a biostimulant and biofertilizer in agriculture. The compound's high biological activity is attributed to its ortho-phenolic groups.
A study from Goethe University Frankfurt reveals that venomous crustaceans, specifically remipede crabs in Mexican cenote caves, contain a variety of toxins with pharmacological potential. The xibalbines peptides effectively inhibit potassium channels and activate signaling pathways involved in pain sensitization.
A research team has developed a simplified synthesis method for organic fluorophores using formaldehyde, reducing molecular size and increasing atomic efficiency. The new technique can also be applied to in vivo environments, showing promise for life sciences research and diagnostics applications.
Researchers from Osaka Metropolitan University have discovered that disruptions in the basement membrane zone between the epidermis and dermis could make it harder for pigment-producing cells to adhere. An enzyme called matrix metalloproteinase 2 (MMP2) may be overexpressed, leading to disturbance of the basement membrane.
Researchers investigated peptide clumping behavior using molecular dynamics simulations and AI techniques. They discovered that aromatic amino acids enhance aggregation, while hydrophilic ones inhibit it, offering insights into peptide structure and function.
Researchers at ETH Zurich have developed a new method to produce billions of pharmaceutically active substances using DNA-encoded chemical libraries. The new method can synthesize and test much larger drug molecules, including ring-shaped peptides, and reduces contamination in the molecular library.
A team of chemists has developed a novel tool to streamline the drug-making process, enabling researchers to create new molecules quickly and efficiently. The discovery of stable nickel complexes can help reduce the time to market for life-saving medicines while increasing drug efficacy and reducing side effects.
Researchers at Universiteit van Amsterdam created a PFAS-free synthesis route for pharmaceutical and agrochemical compounds using a trifluoromethyl group attached to sulfur, nitrogen, or oxygen atoms. The method avoids the use of PFAS reagents, offering an environmentally friendly alternative.
Researchers at the California Institute of Technology have successfully developed a method to recycle samarium diiodide, a crucial reagent in synthesizing molecules that can lead to new pharmaceuticals. This breakthrough enables large-scale industrial production, making it possible to create essential compounds like taxol, an anticance...
Researchers developed a one-pot process to transform aromatic ketones into esters, simplifying the reaction process, reducing reaction times, and minimizing purification steps. The method enables seven different chemical transformations and has shown notable stability and reusability, making it scalable for industrial applications.
Researchers at Heidelberg University have developed a process for producing biologically active peptide boronic acids, which could be used to induce an immune reaction against tumor cells. The new substances also show promise for targeted release of active compounds in the body.
MIT chemists have developed a new way to synthesize complex oligocyclotryptamines found in plants, which could hold potential as antibiotics, analgesics, or cancer drugs. The approach allows for precise assembly of the rings and control of the 3D orientation of each component.
Researchers at Michigan State University characterized how fungi restructure their cell walls to thwart current antifungal medications. The study found that fungi enhance their survival odds by making specific changes to the structure and organization of the components in their cell walls, rendering existing drugs ineffective.
Researchers from Tokyo University of Science develop a new efficient method for Z-alkene synthesis using a recycling photoreactor coupled with HPLC technology. The study yields good yields of Z-alkenes after 4–10 cycles, representing an environmentally friendly and sustainable approach.
A team of researchers developed a new chemical reaction to synthesize ADP- and ATP-containing molecules with high yields, overcoming limitations of traditional methods. The reaction uses a hydrolysis-stable reagent and achieves reproducible access to these molecules.
Researchers at the University of Illinois developed an eco-friendly method to precisely mix fluorine into olefins using natural enzymes and light, offering a more efficient strategy for creating high-value chemicals with potential applications in agriculture, pharmaceuticals, renewable fuels and more.
Researchers have identified a strategy to design safer opioids that suppress pain with fewer side effects. An experimental opioid, RO76, was found to produce a signal within cells that differs from those initiated by classic opioids, leading to reduced breathing rates and withdrawal symptoms.
Studies published in Crystal Growth & Design highlight the suite's ability to visualize and quantify chemical and topological information from crystallographic data. This approach can reduce trial-and-error methods, providing data-driven guidance for formulators and particle engineers.
Researchers at NUS have developed a novel method for creating 1,2-arylheteroaryl ethanes using fundamental feedstock chemicals. The new approach enables the modular assembly of diverse molecular scaffolds with potential applications in pharmaceuticals and petrochemical industries.
Researchers achieved a new method for synthesizing α-substituted carbonyl compounds using a palladium-catalyzed anti-Michael addition reaction. The method produces high-yield products and can be applied to various nucleophiles, including indoles and aromatic compounds.
Researchers develop new method to create azetidines, a stable form of heterocycle that don't oxidize under physiological conditions, expanding toolkit for drug developers to improve medication safety and reduce side effects. This breakthrough enables the creation of more useful chemical transformations with better medical functions.
Researchers discovered Pradimicin A's molecular basis for binding to viral N-glycan, showing promise as an anti-SARS-CoV-2 drug. The compound inhibits SARS-CoV-2 infectivity by interacting with branched oligomannose-containing glycans.
The University of Texas at Arlington's Junha Jeon is developing transition metal-free cross-coupling technologies using arynes to deliver medications safely and effectively. This project aims to improve the production of drugs, particularly for cancer treatment, by reducing impurities left behind by metals.
Scientists have created mirror-image cyclodextrins in the laboratory, which could make it easier to formulate and deliver complex medications. These discoveries may also lead to improved treatment of cardiovascular diseases caused by atherosclerotic plaques.